Allogene Therapeutics, Inc.
ALLO-329
Autoimmune Disease
Countdown
86days
Catalyst readout · ~ Sep 30, 2026 estimated
What's at stake
A key catalyst for ALLO-329 (Autoimmune Disease) is expected ~ Sep 30, 2026.
Primary source
· SEC 8-K
verified 11h ago
“The next update is expected in Q4 2026.”